This confirms that clinical presentation of the patient is more associated with the IL-41 than IL-17 concentrations and that IL-41 may be one of the key cytokines in the pathogenesis of RA with more important role than IL-17. This evidence concerns the gene IL17A and rheumatoid arthritis.